Eric Eisenhauer MD
Specialty:
Gynecologic OncologyTo Schedule an Appointment:
(614) 293-7962Clinical Interests:
treatment of gynecologic malignancies; minimally invasive treatment options; fertility-sparing surgery; radical surgery for advanced and recurrent gynecologic cancer Research Interests:
ovarian cancer genetics; developmental therapies; innovative surgical techniques Biography:
Eric Eisenhauer, MD, is a gynecologic oncologist and assistant professor in the Division of Gynecologic Oncology at The Ohio State University Wexner Medical Center.
His clinical interests are minimally invasive surgery, including robotics, and the surgical management of advanced and recurrent pelvic cancers. He has many research interests, including developing novel therapies for gynecologic cancers.
Born in Seattle, Washington, Dr. Eisenhauer was raised in San Diego, Calif. He received his medical degree from the University of California San Diego School of Medicine. Dr. Eisenhauer completed a residency in obstetrics and gynecology at the Brigham & Women’s and Massachusetts General Hospitals, and was appointed administrative chief resident for his final year. He completed a fellowship in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center under Dr. Richard R. Barakat, and was awarded the Michael G. Burt Memorial Award given annually to the superior graduating fellow in the Department of Surgery. He joined the faculty at Ohio State in 2008.
Dr. Eisenhauer has served on the Education and Program Committees for the Society of Gynecologic Oncology and is a member of the Developmental Therapeutics Committee and Phase I Subcommittee for the Gynecologic Oncology Group. Dr. Eisenhauer has been invited to lecture nationally and internationally on the surgical management of advanced ovarian cancer. He is a member of multiple professional organizations and has published more than 40 original articles and book chapters. At The Ohio State University Comprehensive Cancer Center, he serves on several committees, including the Cancer Institutional Review Board for the last three years.
